Drug research

Tibulizumab Dose A

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Tibulizumab Skin Healing and Inflammation Evaluation for Lasting DefenseNCT06993610	Zura Bio Inc	Phase 2	Active not recruiting	2026-11Estimated

Zura Bio IncActive not recruitingPrimary completion: 2026-11 · Estimated

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.